[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"fetal-monitoring\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:fetal-monitoring":30},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,3,0,[8,44,77],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":4,"overallStatus":31,"whyStopped":4,"lastUpdateSubmitDate":32,"lastUpdatePostDateStruct":33,"startDateStruct":36,"completionDateStruct":38,"leadSponsor":40,"locationsCount":43},"100584757","virtual-reality-based-and-face-to-face-relaxation-programs-in-pregnant-women-with-preeclampsia-100584757",false,"NCT06893510","Virtual Reality-Based and Face-to-Face Relaxation Programs in Pregnant Women With Preeclampsia","The Effect of Virtual Reality-Based and Face-to-Face Relaxation Programs on Maternal and Fetal Outcomes in Pregnant Women With Preeclampsia","Inclusion Criteria:\n\n* Hospitalized with a diagnosis of preeclampsia.\n* Gestational age ≥26 weeks.\n* 18 years or older.\n* Singleton and viable pregnancy.\n* Willing to participate in the study voluntarily.\n\nExclusion Criteria:\n\n* Multiple pregnancy.\n* Pregnancy achieved through assisted reproductive technologies.\n* Hearing or vision impairment in the pregnant individual.\n* Fetal distress requiring emergency intervention.\n* HELLP Syndrome or Eclampsia.\n* History of vertigo.\n\nWithdrawal Criteria:\n\n* Cases where live birth does not occur.\n* Participants who voluntarily withdraw from the study.\n* Participants whose general health condition deteriorates during the intervention.\n* Participants experiencing side effects from virtual reality headset use (e.g., dizziness, nausea, headache).\n* Participants who do not practice progressive muscle relaxation at least once a week after the intervention.","FEMALE","18 Years",{"count":19,"type":20},96,"ESTIMATED","INTERVENTIONAL",[23],"NA","Preeclampsia, affecting 2-8% of pregnancies globally, is a leading hypertensive disorder in pregnancy. It is clinically characterized by elevated blood pressure (≥140\u002F90 mmHg) after the 20th gestational week, often accompanied by proteinuria and systemic complications such as thrombocytopenia, liver dysfunction, and cerebral symptoms. This condition poses significant risks for both maternal and fetal health, increasing the likelihood of organ damage, preterm birth, and long-term cardiovascular and neurodevelopmental complications. Non-pharmacological interventions, including relaxation techniques, have been explored for symptom management. Progressive muscle relaxation (PMR) has shown efficacy in reducing stress, anxiety, and blood pressure. Recently, virtual reality (VR)-based relaxation techniques have gained attention for enhancing stress relief and improving health outcomes. This study aims to compare the effects of VR-based PMR with in-person PMR on maternal and fetal outcomes in preeclamptic pregnancies.",[26,27,28,29,30],"Pre-Eclampsia","Maternal Health","Relaxation","Virtual Reality","Fetal Monitoring","RECRUITING","2026-06-07",{"date":34,"type":35},"2026-06-10","ACTUAL",{"date":37,"type":35},"2025-09-08",{"date":39,"type":20},"2026-09-01",{"name":41,"class":42},"Istanbul University - Cerrahpasa","OTHER",1,{"id":45,"slug":46,"hasResults":11,"nctId":47,"briefTitle":48,"officialTitle":49,"acronym":4,"eligibilityCriteria":50,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":51,"enrollmentInfo":52,"targetDuration":4,"studyType":21,"phases":54,"briefSummary":55,"conditions":56,"keywords":58,"overallStatus":31,"whyStopped":4,"lastUpdateSubmitDate":67,"lastUpdatePostDateStruct":68,"startDateStruct":70,"completionDateStruct":72,"leadSponsor":74,"locationsCount":76},"100595636","evaluation-of-the-fetal-response-to-intrapartum-digital-fetal-scalp-stimulation-to-identify-intrapartum-fetal-hypoxia-100595636","NCT07035028","Evaluation of the Fetal Response to Intrapartum Digital Fetal Scalp Stimulation to Identify Intrapartum Fetal Hypoxia.","Evaluation of Fetal Response to Intrapartum Digital Fetal Scalp Stimulation Upon Detection of Suspected Loss of Fetal Well-being in Suspicious and Pathologic Cardiotocographic Recordings, to Identify Intrapartum Fetal Hypoxia.","Inclusion criteria:\n\nWomen with singleton pregnancy.\n\nCephalic presentation.\n\nGestational age greater than or equal to 37 weeks.\n\nPathological cardiotocographic record according to the criteria published by FIGO and with indication to perform a second-line complementary test, in our case a gold standard test of fetal scalp blood FBS, which confirms or not if there is a risk of loss of fetal well-being and the need for fetal extraction.\n\nSignature of HIP and CI for data collection.\n\nExclusion criteria:\n\nUnder 18 years of age.\n\nContraindication for FBS\n\nUterine dilatation that does not make FBS possible.\n\nHIV\n\nHepatitis\n\nFetuses at increased risk of hemorrhage.","50 Years",{"count":53,"type":20},182,[23],"The main objective of this study is to evaluate whether digital fetal scalp stimulation improves fetal well-being in fetuses with suspicious or pathological cardiotocographic recordings, showing an improvement in cardiotocographic recording patterns and normal values in intrapartum fetal scalp blood results.\n\nUpon detection of a suspicious or pathologic cardiotocographic recording, the investigators need to perform an objective verification of fetal well-being.\n\nCurrently, fetal scalp blood is the reference test to assess intrapartum fetal hypoxia, according to the protocols of the Spanish Society of Gynecology and Obstetrics.\n\nThis procedure lasts about 5 minutes and consists of taking a small sample of the fetal scalp, through a vaginal exploration, the blood is collected in a thin tube and analyzed by a machine in the delivery room obtaining the results in a few minutes.\n\nThe investigators emphasize that this test is not part of the study, as long as the monitor is suspicious or pathological, it will be performed according to protocol to objectively assess fetal well-being.\n\nCurrently there are studies that support the use of fetal scalp stimulation as an alternative technique to assess intrapartum fetal well-being and predict neonatal outcomes, but they also highlight its limited evidence.\n\nDigital fetal scalp stimulation is a NON-invasive method, as no instrument is required and fetal stimulation is a 30-60 second surface rubbing pressure, which is performed manually, through vaginal exploration, the same technique the investigators use to assess dilation during the labor process.\n\nEach patient will be randomly assigned to a study group:\n\nExperimental group: before the extraction of capillary blood from the fetal scalp, fetal head stimulation will be performed, a technique that poses no risk to the baby. The researchers need the consent of the participants to perform this technique and collect data.\n\nControl group: fetal head stimulation will not be applied, but data from the clinical history necessary for this study will be collected.\n\nIn no case will extraordinary or unnecessary tests be performed for participation in this study.\n\nThis study will have an Informed Consent document.\n\nThis study will be carried out at the Fundación Jiménez Díaz and Zarzuela and will include 182 patients for 24 months.",[57,30],"Fetal Hypoxia",[59,60,61,62,63,64,65,66],"digital fetal scalp stimulation dFSS","fetal monitoring","fetal blood sampling FBS","fetal scalp blood","cardiotocography","umbilical cord blood","acidemia","Intrapartum care","2025-06-16",{"date":69,"type":35},"2025-06-24",{"date":71,"type":35},"2024-01-01",{"date":73,"type":20},"2025-12",{"name":75,"class":42},"Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz",2,{"id":78,"slug":79,"hasResults":11,"nctId":80,"briefTitle":81,"officialTitle":81,"acronym":4,"eligibilityCriteria":82,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":83,"enrollmentInfo":84,"targetDuration":4,"studyType":21,"phases":86,"briefSummary":87,"conditions":88,"keywords":89,"overallStatus":31,"whyStopped":4,"lastUpdateSubmitDate":93,"lastUpdatePostDateStruct":94,"startDateStruct":96,"completionDateStruct":98,"leadSponsor":100,"locationsCount":43},"100294305","can-conventional-ecg-technology-capture-fetal-cardiac-activity-100294305","NCT03111173","Can Conventional ECG Technology Capture Fetal Cardiac Activity?","Inclusion Criteria:\n\n* Singleton or twin pregnant women at 32 weeks gestation to full term after routine antepartum testing.\n\nExclusion Criteria:\n\n* None.","55 Years",{"count":85,"type":20},50,[23],"This is a feasibility study for a new application for capturing fetal cardiac activity. The objective of this study is to determine if it is feasible to capture a fetal ECG signal using a Holter ECG device. As comparison we will use a standard Doppler Fetal Heart Rate (FHR) device.",[30],[90,91,92],"ECG","Fetus","R peak extraction","2024-01-16",{"date":95,"type":35},"2024-01-18",{"date":97,"type":35},"2017-06-02",{"date":99,"type":20},"2026-12",{"name":101,"class":42},"University of Washington"]